In this study, we analyzed the TCGA and GTEx databases and found that MTMR2 is significantly overexpressed in various cancer types, including HCC, and that increased expression of MTMR2 is associated with poor patient prognosis. The gene discussed is MTMR2; the disease is hepatocellular carcinoma.